BIOXYNE LIMITED — Capital/Financing Update 2008

Aug 21, 2008

==> picture [223 x 52] intentionally omitted <==

==> picture [37 x 37] intentionally omitted <==

Probiomics Limited ABN 97 084 464 193 Suite 1 A, Level 2 802 Pacific Highway Gordon NSW 2072

P: +61 2 9844 5422 F: +61 2 9844 5445 W: www.probiomics.com.au

The Australian Stock Exchange Limited, Companies Announcements Office SYDNEY

Via: asxonline

22[th] August 2008

Dear sir/madam,

On 31st July 2008 the company announced that it had arranged for the placement of 30,000,000 shares at $0.01 per share through Taylor Collison Ltd. This has now been completed and shares have been allotted as set out in the Appendix 3B lodged on 22 August 2008.

Pursuant to the provisions of Class Order 02/1180, Probiomics Limited confirms that there is no information of the kind that would be required to be disclosed under sub-section 713(5) of the Corporations Act 2001 if a prospectus was to be in reliance on section 713 of the Corporations Act in relation to an offer of securities described above.

Yours sincerely,

==> picture [101 x 50] intentionally omitted <==

Ashok Jairath Company Secretary